Firefly Neuroscience, Inc.
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| – | -1,002.5% | – | – | – | – | |
| – | +3,456.6% | -96.7% | -100.0% | – | +156.7% | |
| – | – | -90.1% | +391.7% | +822.4% | -71.3% | |
| – | – | – | -65.2% | +227.2% | -365.6% | |
| – | -100.0% | – | – | +7.5% | -69.2% | |
| – | – | -83.6% | -247.3% | +23.6% | +421.6% | |
| – | – | -14.5% | -100.0% | – | +29.5% | |
| – | +343.9% | -0.3% | +128.2% | +35.7% | +84.5% | |
| – | -122.1% | – | – | -116.0% | – | |
| – | -1,164.9% | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.